Page 1

EA CONGRESS DV Icahn School of Medicine at NEKTAR® Mount Sinai THERAPEUTICS Multi - omic profiling identifies early molecular responses to rezpegaldesleukin , a novel regulatory T cell - inducing therapy , in atopic dermatitis Meredith Manson , Flavia Manzo Margiotta , Ester Del Duca¹ , Ying Zi ( Jessy ) Meil , Joel Correa da Rosa¹ , Christine Butawo¹ , Manishkumar Patel , Yeriel Estrada ' , Sohail Chaudhry² , Mary Tagliaferri² , Cat Haglund² , Christie Fanton² , Jonathan Zalevsky² , Emma Guttman - Yassky¹ 1 Icahn School of Medicine at Mount Sinai , Dermatology , New York , United States 2 Nektar Therapeutics , San Francisco , California , United States